StockOtters
StockOttersSupply Chain Map
Shanghai Pharmaceuticals Holding Co., Ltd logo

Shanghai Pharmaceuticals Holding Co., Ltd

2607.HK

Financial Statements

Income Statement (Annual)

Amounts in millions

2024

12/31/2024

Revenue
35,783
Cost of Revenue
31,801
Gross Profit
3,982
Gross Margin
11.1%
Operating Income
1,058
Operating Margin
3.0%
Net Income
592
Net Margin
1.7%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,568
EBITDA Margin
4.4%

2023

12/31/2023

Revenue
33,838
Cost of Revenue
29,818
Gross Profit
4,021
Gross Margin
11.9%
Operating Income
997
Operating Margin
2.9%
Net Income
490
Net Margin
1.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,418
EBITDA Margin
4.2%

2022

12/31/2022

Revenue
30,158
Cost of Revenue
26,194
Gross Profit
3,963
Gross Margin
13.1%
Operating Income
1,172
Operating Margin
3.9%
Net Income
730
Net Margin
2.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,618
EBITDA Margin
5.4%

2021

12/31/2021

Revenue
28,057
Cost of Revenue
24,347
Gross Profit
3,711
Gross Margin
13.2%
Operating Income
1,067
Operating Margin
3.8%
Net Income
662
Net Margin
2.4%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,371
EBITDA Margin
4.9%

2020

12/31/2020

Revenue
24,948
Cost of Revenue
21,382
Gross Profit
3,567
Gross Margin
14.3%
Operating Income
934
Operating Margin
3.7%
Net Income
585
Net Margin
2.3%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
1,358
EBITDA Margin
5.4%